Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
  1. 425 Deal Prospectus/Communication re Business Combination
  2. 425 Deal Prospectus/Communication re Business Combination
  3. SC 13D/A Stake Beneficial Ownership Report
  4. SC 13D/A Stake Beneficial Ownership Report
  5. 8-K Event Material agreement · Other events
  6. DEFA14A Proxy Proxy Materials
  7. 10-Q Report Quarterly Report
  8. 8-K Event Executive or director change
  9. 10-Q Report Quarterly Report
  10. 8-K Event Executive or director change
  11. 8-K Event Executive or director change · Other events
  12. SC 13D/A Stake Beneficial Ownership Report
  13. 8-K Event Executive or director change
  14. 10-Q Report Quarterly Report
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change · Regulation FD disclosure
  17. 8-K Event Shareholder vote results
  18. DEFA14A Proxy Proxy Materials
  19. 8-K Event Delisting notice
  20. UPLOAD Other SEC-generated Letter

Page 13 of 19 · 368 filings